"At Sanofi, our purpose has always been to chase the miracles of science to improve people's lives, and our journey with Vula has brought that purpose to life in the most meaningful way.

"Partnering with Vula allowed our Medical team to deliver impactful educational support on Lysosomal Storage Disorders (LSDs), enhancing the knowledge and awareness of Healthcare Professionals across South Africa. This partnership opened doors that would otherwise have remained closed, connecting us with HCPs in ways that would simply not have been possible before.

"The true measure of this journey lies in its impact: patients being tested, HCPs feeling genuinely supported, and clinicians discovering tools that guide them through the most difficult cases and complex patient journeys. Knowing that a healthcare professional feels less alone when navigating a rare disease diagnosis, that is what drives us.

"Vula has been more than a platform; it has been a bridge between knowledge and care, between Sanofi and the HCPs who need us most. Together, we are ensuring that no patient goes undiagnosed and no clinician faces the unknown without support."

Monique Nel | Pharma Medical Head & Rare Disease OBM | Sanofi South Africa